Future Planet Invests in Vaccitech’s Series B Financing
03/17/21, 7:04 AM
Location
londonRound Type
series b
Future Planet Capital has invested in a $168m Series B financing announced today by Vaccitech Ltd. Future Planet joins other leading investors including M&G Investment Management, Tencent, Gilead Sciences, Monaco Constitutional Reserve Fund and fellow existing investor, Oxford Sciences Innovation. As part of the Series B financing, $43 million in convertible loan notes previously issued by Vaccitech will convert into Series B shares, resulting in total gross proceeds to Vaccitech of $168 million before expenses.
Company Info
Location
london, ontario, canada
Additional Info
Future Planet Capital is a global impact-led venture capital firm built to invest in growth companies from the world's top universities. The firm invests in leading entrepreneurs and businesses profitably addressing the world's greatest challenges across Climate Change, Education, Health, Sustainable Growth & Security.